Replies to post #172941 on Cytodyn Inc (CYDY)

[Bill_ENG]

You can go back to Leronlimab's intended use (HIV). Who is the competition there ?

A Gilead exec was brought in. Maybe they thought a fast track to approval would materialize with a big gun on board. Didn't happen, seem like it was a dead period. In that time a company was purchased which has turned out to be useless. This during a critical time in the company development .

Seems like CYDY was being handicapped in retrospect

Now with the 13D another ex Gilead exec pops up out of the woodwork.

Someone was behind the shorts and FUD in 2020. Now many of those, are happy to support the 13D groups takeover. Why ?

Same endgame.

Before the 13D group came out with the 13D filing, someone had posted on a forum that Gilead had bought 60 million shares . Was this the 13D group or separate from them Does Gilead have control of 120 million CYDY shares?

I think it's Gilead Sciences

NP needs to sell out to a bigger Pharma or sell some indications to bolster the war chest.

Results from NASH will bolster a big pharma partnership, LH also, on top of HIV. Success in the Brazil Trials will help.
The next 3 months will be key, and I would be scheduling the annual meeting in October/ November if I was NP.

Stall em, before you beat em.

Jmo